Taxonomy

CMTA Announces New Center of Excellence in Kentucky

The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of

CMTA-STAR Collaboration Celebrates a Decade of CMT Genetic Discovery Through the GENESIS Database

Exciting progress from CMTA’s Strategy To Accelerate Research (STAR) program

Alliance Partner NMD Pharma A/S Launches Phase II SYNAPSE-CMT Trial with First Patient Dosed at CMTA Center of Excellence

The Charcot-Marie-Tooth Association (CMTA) congratulates CMTA-STAR Alliance Partner NMD Pharma

CMTA-INC Strategic Alliance Announces the 2025 Inherited Neuropathy Fellowship

The Charcot-Marie-Tooth Association (CMTA), through its strategic alliance with the

CMTA and INC Forge Groundbreaking Alliance to Accelerate Comprehensive Research Across All Charcot-Marie-Tooth Disease Types

CMTA strengthens its role as the leading force in comprehensive

Advancements in CMT1A and CMT1B Research Highlight CMTA’s Impact

Exciting news from a CMTA-STAR-funded research project has been published

Gene Therapy for CMT1A, 1B, and X1: Progress in Nanoparticles

In a jointly-funded project between CMTA and the Muscular Dystrophy

Progress Update: Timmerman’s CMT1A Organoid Project Shows Early Success

CMTA is excited to report significant progress in its strategic

Breakthrough in CMT1A Research: Community Efforts Drive Success of Dental Stem Cell Model

With the incredible support of the CMT community, Esther Wolfs,

CMTA Partners with Actio Bio on CMT2C Focus Group

The Charcot-Marie-Tooth Association (CMTA), in collaboration with Actio Biosciences (Actio